Mazhar Javaid, MD
Sleep Medicine · Salinas, CANPI 1528091964
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 390 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations.
Across 390 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$2K
- Jazz Pharmaceuticals Inc.$1K
- GSK$1K
- Boehringer Ingelheim$514
- Grifols USA, LLC$403
- AstraZeneca$363
- plus $3K from 29 others
What the payments were for
- Food & beverage$7,93496%
- Education$3394%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 78 | $1,816 |
| Jazz Pharmaceuticals Inc. | 53 | $1,366 |
| GSK | 82 | $1,151 |
| Boehringer Ingelheim | 24 | $514 |
| Grifols USA, LLC | 18 | $403 |
| AstraZeneca(2 entities) | 24 | $363 |
| Avadel CNS Pharmaceuticals, LLC | 10 | $346 |
| Genentech USA, Inc. | 13 | $342 |
| Amgen | 10 | $235 |
| Philips North America LLC | 10 | $202 |
| Sunovion Pharmaceuticals Inc. | 13 | $182 |
| Advanced Respiratory, Inc | 5 | $162 |
| Lilly USA, LLC | 3 | $154 |
| Resmed Corp | 7 | $153 |
| Inspire Medical Systems, Inc. | 3 | $116 |
| United Therapeutics Corporation | 4 | $102 |
| Fisher & Paykel Healthcare Inc | 3 | $77 |
| Alnylam Pharmaceuticals Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Abbott | 2 | $56 |
| Gilead | 3 | $45 |
| Mylan Specialty L.p. | 2 | $41 |
| Electromed, Inc. | 2 | $36 |
| Bayer | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Octapharma USA, Inc. | 1 | $26 |
| Mallinckrodt Enterprises LLC | 1 | $24 |
| Boston Scientific | 1 | $24 |
| AbbVie | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,273 in reported general payments places this provider in the 80th percentile of 200 sleep medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ropinirole Hcl | 46 | $491 |
| Montelukast Sodium | 20 | $134 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Salinas
- Lisa ShivesSan Diego$1.4M
- Haramandeep SinghSan Ramon$1.1M
- Atul MalhotraSan Diego$771K
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Sam KashaniSanta Monica$221K
- Emmanuel MignotStanford$135K
- Jerome HesterPalo Alto$74K
- Mark BuchfuhrerDowney$70K
- Clete KushidaStanford$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.